Rathbones Group’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $293M | Sell |
990,360
-9,170
| -0.9% | -$2.72M | 1.17% | 20 |
|
|
2025
Q4 | $273M | Buy |
999,530
+10,602
| +1% | +$2.88M | 1.07% | 22 |
|
|
2025
Q3 | $267M | Buy |
988,928
+51,570
| +6% | +$14M | 1.08% | 21 |
|
|
2025
Q2 | $258M | Buy |
937,358
+118
| +0% | +$32.1K | 1.11% | 21 |
|
|
2025
Q1 | $249M | Sell |
937,240
-10,092
| -1% | -$2.49M | 1.2% | 19 |
|
|
2024
Q4 | $220M | Sell |
947,332
-368,452
| -28% | -$84.7M | 1.07% | 23 |
|
|
2024
Q3 | $290M | Buy |
1,315,784
+4,310
| +0.3% | +$892K | 1.47% | 13 |
|
|
2024
Q2 | $258M | Buy |
1,311,474
+46,276
| +4% | +$9.56M | 1.4% | 16 |
|
|
2024
Q1 | $272M | Buy |
1,265,198
+216,709
| +21% | +$45.5M | 1.57% | 13 |
|
|
2023
Q4 | $221M | Buy |
1,048,489
+55,433
| +6% | +$11.8M | 1.42% | 15 |
|
|
2023
Q3 | $199M | Buy |
993,056
+19,289
| +2% | +$3.83M | 1.44% | 16 |
|
|
2023
Q2 | $180M | Buy |
973,767
+28,821
| +3% | +$5.33M | 1.68% | 13 |
|
|
2023
Q1 | $181M | Sell |
944,946
-21,967
| -2% | -$3.97M | 1.85% | 12 |
|
|
2022
Q4 | $163M | Buy |
966,913
+22,741
| +2% | +$3.95M | 1.83% | 11 |
|
|
2022
Q3 | $167M | Buy |
944,172
+2,381
| +0.3% | +$471K | 2.06% | 10 |
|
|
2022
Q2 | $193M | Buy |
941,791
+44,337
| +5% | +$9.4M | 2.21% | 8 |
|
|
2022
Q1 | $213M | Buy |
897,454
+40,750
| +5% | +$9.57M | 2.18% | 7 |
|
|
2021
Q4 | $196M | Buy |
856,704
+434,699
| +103% | +$95.6M | 1.9% | 9 |
|
|
2021
Q3 | $81.6M | Buy |
422,005
+58,486
| +16% | +$11.8M | 0.88% | 35 |
|
|
2021
Q2 | $77.3M | Buy |
363,519
+65,550
| +22% | +$13.8M | 0.86% | 35 |
|
|
2021
Q1 | $60.9M | Buy |
297,969
+95,528
| +47% | +$18.8M | 0.78% | 45 |
|
|
2020
Q4 | $36.9M | Buy |
202,441
+29,198
| +17% | +$4.97M | 0.52% | 54 |
|
|
2020
Q3 | $29M | Buy |
173,243
+77,727
| +81% | +$13.1M | 0.5% | 57 |
|
|
2020
Q2 | $15.5M | Buy |
95,516
+29,325
| +44% | +$5.26M | 0.32% | 69 |
|
|
2020
Q1 | $11.4M | Buy |
66,191
+22,666
| +52% | +$4.51M | 0.33% | 67 |
|
|
2019
Q4 | $8.74M | Sell |
43,525
-124,695
| -74% | -$25.6M | 0.23% | 83 |
|
|
2019
Q3 | $35.6M | Buy |
168,220
+15,484
| +10% | +$3.24M | 1.01% | 36 |
|
|
2019
Q2 | $29.6M | Sell |
152,736
-108
| -0.1% | -$19.9K | 0.93% | 45 |
|
|
2019
Q1 | $25.2M | Buy |
152,844
+148,674
| +3,565% | +$26.3M | 0.83% | 46 |
|
|
2018
Q4 | $784K | Buy |
+4,170
| New | +$770K | 0.03% | 185 |
|
Other funds holding CME
VCM
VPM
Rathbones Group's CME Position: Q1 2026 in Review
Rathbones Group reduced its CME Group (CME) stake by 0.92% in Q1 2026, selling an estimated $2.72M and leaving 990,360 shares worth $293M. The position accounts for 1.17% of the portfolio, ranked #20.
Rathbones Group first reported a position in CME in Q4 2018 and has held it in 30 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Rathbones Group held 990,360 shares of CME Group worth $293M as of Q1 2026.
- Rathbones Group sold 9,170 CME Group shares in Q1 2026, an estimated $2.72M.
- CME Group made up 1.17% of Rathbones Group's portfolio in Q1 2026, its #20 holding.
- Rathbones Group first reported a position in CME Group in Q4 2018 and has held it in 30 quarters since.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Rathbones Group's 13F filing for Q1 2026, filed 12 May 2026.